PrakashNeupaneMD

Oncology • Westwood, KS

Head & Neck Cancer, Thoracic Cancer

Professor, Internal Medicine- Medical Oncology University Kansas School of Medicine

Join to view full profile

Dr. Neupane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Neupane's full profile

Already have an account?

Office
2330 Shawnee Mission Pkwy
Westwood, KS 66205
Phone+1 913-588-7750

Fax+1 913-588-4085

Education & Training

Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 2001
St Barnabas HospitalResidency, Internal Medicine, 1995 - 1998
Tribhuvan University Inst of MedicineClass of 1991

Certifications & Licensure

KS State Medical License 2008 - 2025
MO State Medical License 2003 - 2025
LA State Medical License 1998 - 2009
American Board of Internal Medicine Medical Oncology

Clinical Trials

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer Start of enrollment: 2005 Jul 01
Withdrawn
Phase 2
Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
Terminated
Phase 2
A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer Start of enrollment: 2011 Feb 01
Completed
Phase 1
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
PD 0332991 and Cetuximab in Patients With Incurable SCCHN Start of enrollment: 2014 Jun 17
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1634 citations
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...
Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara
Lancet. 2019-11-23
103 citations
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Kevin J Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara
Journal of Clinical Oncology. 2023-02-01
6 citations
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Cherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, Olivier Harismendy, José M Flores
Clinical Cancer Research. 2022-12-01

Press Mentions

Top Doctors in Medical Oncology in Kansas City 2021January 13th, 2021
People Still Lacking Cancer Awareness: DocsNovember 17th, 2018
Breast Cancer Cases on the Rise in NepalOctober 9th, 2017